Revive Therapeutics Ltd (RVVTF)

[Jack Torrance]

Good stuff. But just so we're clear, everyone, enrollment by end of Q1 2022 doesn't mean the trial will be over then. It simply means the 1000th patient will be ENROLLED by March 31st 2022. Which menas the treatment of the last patients could go until the end of April, and then data crunching could go into May, even June if they lallygag like they've been doing. And then of course they could be delayed again, as deadlines are often not met. We could get a PR in March stating that enrollment hasn't been what they expected, and the trial will push into Q2.

In other words, we are still more than 2 months away. This is a very bullish PR, but let's not start assuming we are going to get FDA approval in 4-6 weeks or anything.